Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-06-03 14:16 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
Filed 2025-03-20 12:19 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
306,000 | |
Filed 2025-03-20 12:19 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
Filed 2024-12-10 13:51 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
268,500 | |
Filed 2024-12-10 13:50 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
Filed 2024-12-02 19:16 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,000 vol |
231,000 | |
Filed 2024-12-02 19:15 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-75,000 vol |
75,000 | |
Filed 2024-11-26 16:16 Tx date 2024-11-25 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,000
-100,000 vol $0.30 each |
156,000 | |
Filed 2024-11-22 12:16 Tx date 2024-11-21 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+250,000 vol $0.05 each |
256,000 | |
Filed 2024-11-22 12:15 Tx date 2024-11-21 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-250,000 vol $0.05 each |
100,000 | |
Filed 2024-03-02 09:11 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
Filed 2024-03-02 09:10 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-01-31 17:24 Tx date 2022-01-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+6,000 vol $0.06 each |
6,000 | |
Filed 2022-01-31 17:20 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|